Skip to main content Skip to navigation

News

  1. News papers stacked up, neat piles

    Dimethyl fumarate (BG-12, Tecfidera) - NICE confirms approval in final guidance

    27 August 2014

    Dimethyl fumarate (BG-12, Tecfidera) will start to be available on the NHS in England and Wales from November following final guidance from NICE (National Institute for Health and Care Excellence). Read more…

  1. Glasses on a newspaper

    Dimethyl fumarate (Tecfidera) approved in England and Wales

    27 August 2014

    NICE has issued its final guidance approving Tecfidera for treating people with relapsing remitting MS England and Wales.
    Read more…

  1. Small sample dishes

    anti-LINGO-1 study

    27 August 2014

    A potential new MS treatment that works by encouraging damaged myelin to regrow has been found to be 'safe and tolerable' in a phase 1 study. The trial wasn't looking at any therapeutic effect.
    Read more…

  1. MS Trust news board

    Dimethyl fumarate (BG-12, Tecfidera) - NICE confirms approval in final guidance

    27 August 2014

    Dimethyl fumarate (BG-12, Tecfidera) will start to be available on the NHS in England and Wales from November following final guidance from NICE (National Institute for Health and Care Excellence). Read more…

  1. Beaker and flask pouring blue liquid

    New vacancy: Clinical Nurse Specialist for Multiple Sclerosis at the Royal Berkshire Hospital

    27 August 2014

    An exciting opportunity has arisen to join the neurological team based at the Royal Berkshire Hospital as a Clinical Nurse Specialist for Multiple Sclerosis. The CNS post is a varied and supporting patients with MS as well as their families throughout the disease trajectory - diagnostic phase to severe disability phase. Read more…

  1. MS Trust collection box

    Good luck to our 3 Cities cyclists

    26 August 2014

    Good luck to the five MS Trust supporters who set off on Wednesday to cycle from London to Brussels via Amsterdam - a total of over 330 miles in just four days! Read more…